Yatsuhashi Hiroshi
Clinical Research Center, National Hospital Organization, Nagasaki Medical Center, Nagasaki, Japan.
Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):49-51. doi: 10.5005/jp-journals-10018-1166. Epub 2016 Jul 9.
Of all the industrialized countries of the world, Japan has the highest rate of hepatitis C. It also has 1 of the oldest and most varied histories of hepatitis C in the world among the industrialized modern nations. Hepatitis C and its complications are the leading cause of liver cancer in Japan. Japan has the highest rate of liver cancer among the industrialized countries. From 2004 to 2014, PegIFN/RBV treatment was the mainstream of hepatitis C treatment. In 2014, the first interferon-free therapy was approved in Japan. Subsequently, other interferon-free therapies have been approved. Hepatitis C virus disinfection in hepatitis C patients in Japan has become possible with a probability of 96% or more.
Yatsuhashi H. Past, Present, and Future of Viral Hepatitis C in Japan. Euroasian J Hepato-Gastroenterol 2016;6(1):49-51.
在世界所有工业化国家中，日本丙型肝炎发病率最高。在工业化现代国家中，日本也是世界上丙型肝炎历史最悠久、情况最多样化的国家之一。丙型肝炎及其并发症是日本肝癌的主要病因。日本在工业化国家中肝癌发病率最高。2004年至2014年期间，聚乙二醇干扰素/利巴韦林治疗是丙型肝炎治疗的主流方法。2014年，日本批准了首个无干扰素疗法。随后，其他无干扰素疗法也获得批准。日本丙型肝炎患者的丙型肝炎病毒消毒成功率达到96%或更高。
八桥博。日本丙型病毒性肝炎的过去、现在和未来。《欧亚肝脏胃肠病学杂志》2016年；6(1):49 - 51。
